Current Edition

News

First patients enrolled for Priothera’s mocravimod trial

Treatment is a maintenance therapy for certain patients with acute myeloid leukaemia Priothera – a company focused on the development of a sphingosine 1 phosphate …

Continue Reading →
News

OxSonics trial produces positive SonoTran data

During the research, SonoTran is being evaluated in patients with metastatic colorectal cancer. OxSonics Therapeutics – a company focused on cancer treatment through SonoTran – …

Continue Reading →
News

NICE recommends Takeda’s Ninlaro triplet regimen

Therapy involves patients living with relapsed or refractory multiple myeloma. Takeda has announced that the National Institute for Health and Care Excellence (NICE) has recommended …

Continue Reading →
News

NeoPhore gains additional financing for discovery pipeline

The new funding package will be used to progress NeoPhore’s expanding pipeline of therapies. NeoPhore – a small molecule neoantigen immuno-oncology company – has announced …

Continue Reading →
News

Stada and Xbrane receive approval for Ximluci

Biosimilar gains MHRA marketing authorisation for use throughout Britain. Stada and Xbrane have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has …

Continue Reading →
News

Medicines Discovery Catapult and SMi gain cancer biomarker funding

Industry-first cancer screening technology boosted by biomedical grant funding. SMi and the Medicines Discovery Catapult (MDC) have secured a biomedical catalyst (BMC) grant to establish …

Continue Reading →
News

Celadon receives good manufacturing practice approval

MHRA approval relates to the company’s midlands-based drug development facilities. Celadon – a company focused on the development of cannabis-based medicines – has announced that …

Continue Reading →
News

AbbVie and Eli Lilly snub drug pricing agreement

Major industry names depart leaving UK pricing deal in serious jeopardy. Global pharma giants, AbbVie and Eli Lilly and Company (Lilly), have shocked the UK …

Continue Reading →
News

AstraZeneca’s Tezspire receives approval for asthma treatment

Green light for new asthma pen which offers a self-administration option across the EU. AstraZeneca’s (AZ) Tezspire has received a positive opinion from the European …

Continue Reading →
News

Moderna becomes latest company to join the ABPI

The company becomes the latest member of the ABPI and galvanises the company’s UK connections. Moderna is the latest member of the UK’s leading pharmaceutical …

Continue Reading →